In 1905, Charles Henry Robinson spotted a unique opportunity.
After moving west with his family to the North Dakota town of Grand Forks, he soon realized that settlers were in need of supplies. He founded a transportation company with the goal of delivering perishable products to consumers before they spoiled -- a difficult challenge in the horse-and-buggy days.
The company Robinson founded changed with the times, taking advantage of historic advances in the transportation industry. These advances included the first refrigerated truck (without ice) in 1939, the construction of the interstate highway system beginning in 1945, and the deregulation of the trucking industry in 1980.
Deregulation allowed the company freedom in setting its own rates. It also freed up the types of cargo that could be carried and the geographical areas in which the company could operate.
As it's known today, C.H. Robinson (Nasdaq: CHRW) has again changed with the times.
Top 10 Transportation Stocks To Invest In Right Now: Travelzoo Inc(TZOO)
Travelzoo Inc., an Internet media company, together with its subsidiaries, publishes travel and entertainment deals from travel and entertainment companies, and local businesses in North America and Europe. Its publications and products include the Travelzoo Websites, such as travelzoo.com, travelzoo.ca, travelzoo.co.uk, travelzoo.de, www.travelzoo.es, and travelzoo.fr; the Travelzoo Top 20 e-mail newsletter; and the Newsflash e-mail alert service. The company also operates SuperSearch, a pay-per-click travel search tool; Travelzoo Network, a network of third-party Websites that list deals published by Travelzoo; and Fly.com, a travel search engine that allows users to find the best prices on flights from various airlines and online travel agencies. In addition, it provides Local Deals and Getaways services that allow its subscribers to purchase vouchers for deals from local businesses, such as spas, hotels, and restaurants through the Travelzoo Website. As of December 31, 2011, the company?s advertiser base included approximately 2,000 travel companies, entertainment companies, and local businesses, including airlines, hotels, cruise lines, vacations packagers, tour operators, destinations, car rental companies, travel agents, theater and performing arts groups, restaurants, spas, and activity companies. Travelzoo Inc. was founded in 1998 and is headquartered in New York, New York.
Advisors' Opinion:- [By Rich Smith]
If you are a Travelzoo (NASDAQ: TZOO ) shareholder but own fewer than 25 shares, management would really appreciate it if you would just go away.
- [By Tom Taulli]
Valuation: Even with after the Expedia stock sell-off, shares of EXPE remain far from cheap. EXPE stock is trading for a trailing P/E of 46 vs. 33 for Priceline and 23 for Travelzoo (TZOO).�And considering the recent volatility, investors are certainly jittery about EXPE stock. As a result, another earnings disappointment could have a severe impact.
Top Trucking Stocks To Invest In Right Now: Senomyx Inc.(SNMX)
Senomyx, Inc. engages in the discovery and development of novel flavor ingredients in the savory, sweet, salt, bitter, and cooling areas using proprietary taste receptor-based assays and screening technologies. The company has product discovery, development, and commercialization collaborations with seven food, beverage, and ingredient companies, including Ajinomoto Co., Inc.; Firmenich SA; Kraft Foods, Inc.; Nestle SA; and PepsiCo, Inc. Senomyx, Inc. licenses flavor ingredients to its collaborators on an exclusive or co-exclusive basis. The company was founded in 1998 and is based in San Diego, California.
Advisors' Opinion:- [By Roberto Pedone]
Senomyx (SNMX) discovers, develops and commercializes flavor ingredients for the packaged food, beverage and ingredient supply industries using proprietary taste receptor-based assays and screening technologies. This stock closed up 10.4% to $8.49 in Thursday's trading session.
Thursday's Range: $7.70-$8.62
52-Week Range: $3.27-$12.74
Thursday's Volume: 622,000
Three-Month Average Volume: 425,867From a technical perspective, SNMX ripped sharply higher here right above some near-term support at $7.66 and back above its 50-day moving average of $8.68 with above-average volume. This stock has formed a major bottoming chart pattern over the last month and change, with shares finding buying interest at $7.39, $7.55 and $7.66 a share. Shares of SNMX are now starting to spike sharply higher above those support levels and it's quickly moving within range of triggering a major breakout trade. That trade will hit if SNMX manages to take out its 50-day moving average of $8.68 and then once it clears more key overhead resistance levels at $9.38 to $10.11 with high volume.
Traders should now look for long-biased trades in SNMX as long as it's trending above its 200-day at $8.04 or above some more near-term support at $7.66 and then once it sustains a move or close above those breakout levels with volume that hits near or above 425,867 shares. If that breakout triggers soon, then SNMX will set up to re-test or possibly take out its next major overhead resistance levels at $12 to its 52-week high at $12.74.
Top Trucking Stocks To Invest In Right Now: Morgan Stanley (INR)
Morgan Stanley, incorporated on January 10, 1981, is a global financial services company that, through its subsidiaries and affiliates, provides its products and services to a range of clients and customers, including corporations, governments, financial institutions and individuals. The Company is a financial holding company. The Company operates in three segments: Institutional Securities, Global Wealth Management Group and Asset Management. The Company provides financial advisory and capital-raising services to a group of corporate and other institutional clients worldwide. As of December 31, 2011, the Company�� Global Wealth Management Group had $1,649 billion in client assets. The Company�� Asset Management business segment offers clients an array of equity, fixed income and alternative investments and merchant banking services. In December 2013, the Company announced that it has sold the majority of its global physical oil trading operations to Rosneft' NK OAO.
Institutional Securities
The Company provides financial advisory and capital-raising services primarily through wholly owned subsidiaries that include Morgan Stanley & Co. LLC (MS&Co.), Morgan Stanley & Co. International plc and Morgan Stanley Asia Limited, and certain joint venture entities that include Morgan Stanley MUFG Securities Co., Ltd. (MSMS) and Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. (MUMSS). The Company, primarily through these entities, also conducts sales and trading activities worldwide, as principal and agent, and provides related financing services on behalf of institutional investors. The Company manages and participates in public offerings and private placements of debt, equity and other securities worldwide. The Company is an underwriter of common stock, preferred stock and other equity-related securities, including convertible securities and American depositary receipts (ADRs). The Company is also an underwriter of fixed income securities, including investment-grade debt, non-i! nvestment-grade instruments, mortgage-related and other asset-backed securities, tax-exempt securities and commercial paper and other short-term securities.
The Company provides corporate and other institutional clients worldwide with advisory services on matters, such as mergers and acquisitions, divestitures, joint ventures, corporate restructurings, recapitalizations, spin-offs, exchange offers and leveraged buyouts and takeover defenses, as well as shareholder relations. The Company also provides advice concerning rights offerings, dividend policy, valuations, foreign exchange exposure, financial risk management strategies and financial planning. In addition, the Company provides advice and services regarding project financings and provides advisory services in connection with the purchase, sale, leasing and financing of real estate. The Company provides loans or lending commitments, including bridge financing, to selected corporate clients through its subsidiaries, including Morgan Stanley Bank, N.A (MSBNA).
The Company conducts sales, trading, financing and market-making activities on securities and futures exchanges and in over-the-counter (OTC) markets worldwide. The Company�� Institutional Securities sales and trading activities consists of Equity Trading; Fixed Income and Commodities; Clients and Services; Research, and Investments. The Company acts as principal (including as a market-maker) and agent in executing transactions worldwide in equity and equity-related products, including common stock, ADRs, global depositary receipts and exchange-traded funds. The Company�� equity derivatives sales, trading and market-making activities cover equity-related products worldwide, including equity swaps, options, warrants and futures overlying individual securities, indices and baskets of securities and other equity-related products. The Company also issues and makes a principal market in equity-linked products to institutional and individual investors.
The ! Company t! rades, invests and makes markets in fixed income securities and related products globally, including, among other products, investment and non-investment grade corporate debt, distressed debt, bank loans, the United States and other sovereign securities, emerging market bonds and loans, convertible bonds, collateralized debt obligations, credit, currency, interest rate and other fixed income-linked notes, securities issued by structured investment vehicles, mortgage-related and other asset-backed securities and real estate-loan products, municipal securities, preferred stock and commercial paper, money-market and other short-term securities. The Company is a dealer of the United States federal government securities and a member of the selling groups that distribute various the United States agency and other debt securities. The Company is also a dealer or market-maker of government securities in European, Asian and emerging market countries.
The Company trades, invests and makes markets globally in listed futures and OTC swaps, forwards, options and other derivatives referencing, among other things, interest rates, currencies, investment grade and non-investment grade corporate credits, loans, bonds, the United States and other sovereign securities, emerging market bonds and loans, credit indexes, asset-backed security indexes, property indexes, mortgage-related and other asset-backed securities and real estate loan products. The Company trades, invests and makes markets in foreign currencies, such as the British pound, Canadian dollar, euro, Japanese yen and Swiss franc, as well as in emerging markets currencies. The Company trades these currencies on a principal basis in the spot, forward, option and futures markets.
The Company advises on investment and liability strategies and assists corporations in their debt repurchases and tax planning. The Company invests and makes markets in the spot, forward, physical derivatives and futures markets in several commodities, including ! metals (b! ase and precious), agricultural products, crude oil, oil products, natural gas, electric power, emission credits, coal, freight, liquefied natural gas and related products and indices. The Company is a market-maker in exchange-traded options and futures and OTC options and swaps on commodities, and offers counterparties hedging programs relating to production, consumption, reserve/inventory management and structured transactions, including energy-contract securitizations and monetization. The Company is an electricity power marketer in the United States and owns electricity-generating facilities in the United States and Europe.
The Company owns TransMontaigne Inc. and its subsidiaries, a group of companies operating in the refined petroleum products marketing and distribution business, and owns a minority interest in Heidmar Holdings LLC, which owns a group of companies that provide international marine transportation and the United States marine logistics services. The Company provides financing services, including prime brokerage, which offers, among other services, consolidated clearance, settlement, custody, financing and portfolio reporting services to clients trading multiple asset classes. In addition, the Company�� institutional distribution and sales activities are overseen and coordinated through Clients and Services.
The Company�� research department (Research) coordinates worldwide across all of the Company�� businesses and consists of economists, strategists and industry analysts who engage in equity and fixed income research activities and produce reports and studies on the United States and global economy, financial markets, portfolio strategy, technical market analyses, individual companies and industry developments. The Company from time to time makes investments that represent business facilitation or other investing activities. From time to time, the Company may also make investments and capital commitments to public and private companies, funds and oth! er entiti! es. The Company�� Operations and Information Technology departments provide the process and technology platform that supports Institutional Securities sales and trading activity, including post-execution trade processing and related internal controls over activity from trade entry through settlement and custody, such as asset servicing.
Global Wealth Management Group
The Company�� Global Wealth Management Group, which includes the Company�� 51% interest in Morgan Stanley Smith Barney Holdings LLC (MSSB), provides financial services to clients. During the year ended December 31, 2011, the Company had a network of more than 17,500 global representatives in approximately 765 locations. Global Wealth Management Group professionals serve individual investors and small-to-medium sized businesses and institutions with focus on ultra-high-net-worth, high-net-worth and affluent investors. Global representatives are located in branches across the United States. Outside the United States, Global Wealth Management Group offers financial services to clients in Europe, the Middle East, Asia, Australia, Canada and Latin America.
The Company�� Global Wealth Management Group provides clients with an array of financial solutions, including products and services from the Company, Citigroup Inc. (Citi) and third-party providers, such as insurance companies and mutual fund families. Global Wealth Management Group provides brokerage and investment advisory services covering various types of investments, including equities, options, futures, foreign currencies, precious metals, fixed income securities, mutual funds, structured products, alternative investments, unit investment trusts, managed futures, separately managed accounts and mutual fund asset allocation programs. Global Wealth Management Group also engages in fixed income principal trading, which primarily facilitates clients��trading or investments in such securities. In addition, Global Wealth Management Group offers ! education! savings programs, financial and wealth planning services, and annuity and other insurance products.
Global Wealth Management Group offers its clients access to several cash management services through various banks and other third parties, including deposits, debit cards, electronic bill payments and check writing, as well as lending products through affiliates, such as Morgan Stanley Private Bank, National Association (MS Private Bank) and MSBNA, including securities-based lending, mortgage loans and home equity lines of credit. Global Wealth Management Group also provides trust and fiduciary services, offers access to cash management and commercial credit solutions to qualified small- and medium-sized businesses in the United States, and provides individual and corporate retirement solutions, including individual retirement accounts and 401(k) plans and the United States and global stock plan services to corporate executives and businesses. Global Wealth Management Group provides clients a variety of ways to establish a relationship and conduct business, including brokerage accounts with transaction-based pricing and investment advisory accounts with asset-based fee pricing.
Asset Management
The Company's portfolio managers located in the United States, Europe and Asia manage investment products ranging from money market funds to equity and fixed income strategies, alternative investment and merchant banking products in developed and emerging markets across geographies and market cap ranges. The Company offers a range of alternative investment, real estate investing and merchant banking products for institutional investors and high net worth individuals. The Company�� alternative investments platform includes funds of hedge funds, funds of private equity funds and portable alpha strategies. The Company�� alternative investments platform also includes minority interest in Lansdowne Partners, Avenue Capital Group and Traxis Partners LP. The Company�� real e! state and! merchant banking businesses include its real estate investing business, private equity funds, corporate mezzanine debt investing group and infrastructure investing group.
The Company acts as general partner of, and investment adviser to, its alternative investment, real estate and merchant banking funds. The Company provides investment management strategies and products to institutional investors worldwide, including corporations, pension plans, endowments, foundations, sovereign wealth funds, insurance companies and banks through a range of pooled vehicles and separate accounts. It also provides sub-advisory services to various unaffiliated financial institutions and intermediaries. The Company offers open-end and alternative investment funds and separately managed accounts to individual investors through affiliated and unaffiliated broker-dealers, banks, insurance companies, financial planners and other intermediaries. Closed-end funds managed by the Company are available to individual investors through affiliated and unaffiliated broker-dealers. The Company also distributes mutual funds through a range of retirement plan platforms. Internationally, the Company distributes traditional investment products to individuals outside the United States through distributors and distributes alternative investment products through affiliated broker-dealers and banks. The Company�� Operations and Information Technology departments provide or oversee the process and technology platform required to support its asset management business. Support activities include transfer agency, mutual fund accounting and administration, transaction processing and certain fiduciary services on behalf of institutional, intermediary and high net worth clients.
Advisors' Opinion:- [By Jon C. Ogg]
Market Vectors Indian Rupee/USD ETN (NYSEMKT: INR) and WisdomTree Indian Rupee (NYSEMKT: ICN) are both performing poorly as well in the currency exchange traded note (ETN) world, although their trading volume is too thin to monitor.
Top Trucking Stocks To Invest In Right Now: Quest Diagnostics Inc (DGX)
Quest Diagnostics Incorporated (Quest Diagnostics), incorporated in 1990, is a provider of diagnostic testing, information and services, providing insights that enable patients and physicians to make healthcare decisions. Quest Diagnostics offers United States patients and physicians the access to diagnostic testing services through its nationwide network of laboratories and Company-owned patient service centers. The Company provides interpretive consultation through the medical and scientific staff. The Company is a provider of clinical testing, including gene-based and esoteric testing and anatomic pathology services, and the provider of risk assessment services for the life insurance industry. The Company also is a provider of testing for clinical trials and testing for drugs of abuse. Its diagnostics products business manufactures and markets diagnostic test kits and specialized point-of-care testing. On April 4, 2011, the Company acquired Athena Diagnostics (Athena). On May 17, 2011, the Company acquired Celera Corporation (Celera). In January 2012, the Company acquired S.E.D. Medical Laboratories. In December 2012, the Company sold all of the assets of OralDNA Labs salivary-diagnostics business to Access Genetics. Quest Diagnostics Incorporated (Quest Diagnostics) is a provider of diagnostic testing, information and services, providing insights that enable patients and physicians to make healthcare decisions. Quest Diagnostics offers United States patients and physicians the access to diagnostic testing services through its nationwide network of laboratories and Company-owned patient service centers. The Company provides interpretive consultation through the medical and scientific staff. The Company is a provider of clinical testing and the provider of risk assessment services for the life insurance industry. The Company also is a provider of testing for clinical trials and testing for drugs of abuse. In January 2012, it acquired S.E.D. Medical Laboratories. In December 2012, it sold all of the ! assets of OralDNA Labs salivary-diagnostics business to Access Genetics. In January 2013, the Company acquired the Worcester -based clinical outreach laboratory business of UMass Memorial Medical Center.
Clinical Testing
The Company is a commercial clinical testing company. Physicians use clinical tests to assist in the detection, diagnosis, evaluation, monitoring and treatment of diseases and other medical conditions. Clinical testing is generally categorized as clinical laboratory testing and anatomic pathology services. The Company offers customers the access to the test menu of clinical laboratory and anatomic pathology tests in the United States. Clinical laboratory testing generally is performed on whole blood, serum, plasma and other body fluids, such as urine, and specimens such as microbiology samples.
The Company is a provider of routine clinical testing, including testing for drugs of abuse. The Company performs routine testing through its network of laboratories and rapid response laboratories. The Company also performs routine testing at hospital laboratories that the Company manages. The Company operates laboratories round the clock. The majority of test results are delivered electronically. Routine tests measure various bodily health parameters, such as the functions of the kidney, heart, liver, thyroid and other organs. Commonly ordered tests include blood chemistries, including cholesterol levels; complete blood cell counts; urinalysis; pregnancy and other prenatal tests, and routine microbiology testing.
The Company is a provider of anatomic pathology services in the United States, through its AmeriPath, Dermpath Diagnostics and Quest Diagnostics brands. Anatomic pathology involves the diagnosis of cancer and other diseases and medical conditions through examination of tissue and cell samples taken from patients. The Company provides inpatient anatomic pathology and medical director services at hospitals throughout the country, and through ! its labor! atories. The Company provides a range of services to all anatomic pathology subspecialties. The Company provides integrated, reports that include both anatomic pathology and clinical pathology tests, enabling its pathologists to offer patients and physicians a complete analysis. The Company introduced the Leumeta family of tests for leukemia and lymphoma.
The Company is a provider in the United States of gene-based and esoteric testing. Esoteric tests include procedures in the areas of molecular diagnostics, protein chemistry, cellular immunology and advanced microbiology. Commonly ordered esoteric tests include viral and bacterial detection tests, drug therapy monitoring tests, genetic tests, autoimmune panels and complex cancer evaluations. During the year ended December 31, 2011, it acquired Athena Diagnostics, a provider of neurology testing. Its esoteric laboratories provide reference testing services to physicians, academic medical centers, hospitals and other commercial laboratories. The Company also offers gene-based tests for the predisposition, diagnosis, treatment and monitoring of cancers. The Company develops tests at its laboratories, such as Quest Diagnostics Nichols Institute. It also develops techniques and services in anatomic pathology.
In 2011, the Company introduced its melanoma treatment selection mutation panel, which is designed to assist in the personalized selection of patient therapies. The Company introduced its thyroid cancer mutation panel, which assists in the diagnosis of thyroid cancer and aids physicians and surgeons as they plan surgery and other therapies to treat and attempt to cure thyroid cancer. During 2011, it enhanced its SureSwab Vaginosis/Vaginitis Plus test. The Company introduced Accutype IL28b, a test designed to aid in the prediction of patient response to peginterferon alpha-based therapy for treating hepatitis C virus infection. In 2011, it introduced testing for very long chain fatty acids, to assist in diagnosis and monitori! ng of inh! erited disorders of fatty acid metabolism. It also introduced high resolution chromosomal analysis testing with oligonucleotide microarrays to enhance its testing services in the pre-natal and post-natal genetics areas. During 2011, the Company released a test for therapeutic drug monitoring of dabigatran, an oral anti-coagulant. The Company also released genetic testing for SLC01B1, which helps identify patients at risk for myopathy from Simvastatin therapy for cholesterol reduction. Through Athena Diagnostics, it launched several molecular genetic tests for stroke, neuromuscular diseases and mitochondrial disorders.
Healthcare Information Technology
The Company provides interoperable technologies that help healthcare organizations and physicians enter, share and access clinical information without costly information technology (IT) implementation or workflow disruption, including through its Care360 suite of products and its ChartMaxx electronic document management system for hospitals. These solutions offer access to a national healthcare provider network, including approximately 200,000 networked physicians and clinicians using Quest Diagnostics��Care360 connectivity products. The Care360 products, including its Care360 Labs and Meds, enable physicians electronically to order diagnostic tests and review test results from Quest Diagnostics and electronically to prescribe medication. As of December 31, 2011, prescriptions were written through Care360 ePrescribing at an annualized rate of 32 million medications. Using its Care360 connectivity products, physicians can securely provide diagnostic and other data to a patient�� account. It offers Gazelle, a secure mobile health platform that allows users to receive their Quest Diagnostics laboratory results, manage their personal health information, find a Quest Diagnostics location and schedule appointments directly from their smartphone.
Clinical Trials Testing
The Company is a provider of central l! aboratory! testing performed in connection with clinical research trials on new drugs, vaccines and certain medical devices. It has clinical trials testing centers in the United States and the United Kingdom, and it provides clinical trials testing in Argentina, Australia, Brazil, the People�� Republic of China and Singapore through affiliated laboratories. The Company has biomarker capabilities. In 2011, it acquired Celera, enhancing its ability to provide biomarker discovery and develop IVD test kits.
Life Insurer Services
The Company is a provider of risk assessment services to the life insurance industry in North America. It also provides risk assessment services for insurance companies doing business in many countries outside the United States. Its risk assessment services comprise underwriting support services to the life insurance industry, including laboratory testing, electronic data collection, specimen collection and paramedical examinations, medical record retrieval, case management, motor vehicle reports, telephone inspections, prescription histories and credit checks. The laboratory tests that it performs and data it gathers are designed to assist insurance companies to objectively evaluate the mortality risks of policy applicants. The majority of the testing is performed on specimens of life insurance applicants, but also includes specimens of applicants for other types of insurance. Most of its specimen collections and paramedical examinations are performed by its network of approximately 5,000 contracted paramedical examiners at the applicant�� home or workplace. The Company also offers paramedical examinations through approximately 500 of its patient service centers, and operate approximately 80 locations other than patient service centers in the United States and Canada where the Company provides paramedical examinations, bringing to approximately 580 the total number of sites where it can provide these examinations. The Company also contracts with third parties at over! an addit! ional 200 locations globally to coordinate providing these exams.
Employer Services
The Company is a provider of testing to employers for the detection of employee use of drugs of abuse. Its Quest Diagnostics Drug Testing Index, which is an annual report of its aggregate drug testing results, is used by employers, the federal government and the media to help identify and quantify drug abuse among the nation�� workforce. It provides a range of solutions for drugs of abuse, including urine, hair, blood and oral fluid tests. In 2011, it introduced Oral-Eze, its own oral fluid collection system that simplifies the collection of oral samples for routine drug testing. The Oral-Eze Oral Fluid Collector provides all the advantages of previous collection systems, with the added benefit of its indicator window technology. The Company provides wellness testing and analytic services to employers.
Diagnostic Products
Diagnostic Products include point-of-care, or near-patient and testing. The Company develops and manufactures products that enable healthcare professionals to make healthcare diagnoses, including products for point-of-care, or near-patient, testing for the professional market. The Company has several companies, including Focus Diagnostics, HemoCue and Celera. Focus Diagnostics is a provider of infectious disease testing. Focus Diagnostics develops, manufactures and markets diagnostic products, such as HerpeSelect ELISA tests that detect patient antibodies to specific types of herpes simplex virus, which can be performed on a variety of instrument platforms. Focus Diagnostics sells its diagnostic products to academic medical centers, hospitals and commercial laboratories globally. Focus Diagnostics has an agreement with 3M Corporation for global human diagnostic rights to a compact integrated bench-top instrument for use with real time polymerase chain reaction (PCR) assays. These tests are sold under the Simplexa brand name. In 2011, Focus Diagnostic! s receive! d the CE mark to offer Simplexa tests in Europe, including tests for Cytomegalovirus, Epstein Barr virus, BK virus and clostridium difficile. Focus Diagnostics offers molecular transplant-testing menus in Europe.
HemoCue manufactures and distributes point-of-care testing products globally. HemoCue is a global provider in point-of-care testing for hemoglobin, with a growing market share for glucose, microalbumin and white blood cell testing. HemoCue offers its White Blood Cell Differential System in Europe. Celera offers complexity molecular diagnostic products in segments, such as HIV-1 drug resistance testing, reproductive genetics, transplantation and cardiovascular genetics. It also manufactures and offers the InSure fecal immunochemical test (FIT) for screening for colorectal cancer.
The Company competes with Laboratory Corporation of America Holdings, Inc.
Advisors' Opinion:- [By James E. Brumley]
And make no mistake - organizations are getting on board. Quest Diagnostics (NYSE:DGX) agreed to lease access to the tool back in November of last year for an undisclosed, but multi-year, term. CellNetix Pathology & Laboratories as well as Cynvenio Biosystems are also now renters of access to the specialized site.
- [By Sean Williams]
Thinking really long-term
Sometimes we need to put on our Warren Buffett goggles and think like Buffett if we hope to find the market's best buy-and-hold opportunities. This week I feel could represent the perfect opportunity to nab shares of medical diagnostics company Quest Diagnostics (NYSE: DGX ) , which are still relatively close to a 52-week low.
Top Trucking Stocks To Invest In Right Now: Redhill Biopharma Ltd (RDHL)
Redhill Biopharma Ltd. is an Israel-based biopharmaceutical company. The Company is focused on the development and acquisition of therapeutic candidates. The Company�� pipeline consists of six late clinical development therapeutic candidates, two of which have completed bioequivalence clinical trials subject to review and approval by the United States Food and Drug Administration and, in some cases, regulatory authorities in other countries. The Company�� six clinical stage therapeutic candidates include RHB-101, RHB-102, RHB-103, RHB-104, RHB-105 and RHB-106.
RHB-101
RHB-101 is a treatment of hypertension, heart failure and left ventricular dysfunction (following myocardial infraction) by means of controlled release of an active ingredient known as carvedilol, which is designed to be administered to patients on a once-daily basis. RHB-101 is based on a patented technology for the controlled release of drugs administered orally.
RHB-102
RHB-102 is a once-daily controlled release oral formulation of ondansetron. RHB-102 utilizes a technology called CDT that uses salts to provide a controlled release of ondansetron.
RHB-103
RHB-103 is an oral thin film formulation of rizatriptan intended for the treatment of acute migraine headaches. Migraine is a neurovascular disorder (related to nerves and blood vessels) characterized by recurrent headaches in one side or both sides of the head.
The product is based on a technology called VersaFilm.
RHB-104
RHB-104 is an antibiotic combination therapy for the treatment of Crohn's disease (with a PIII clinical study underway), as well as Multiple Sclerosis (with an ongoing PIIa clinical study) and Rheumatoid Arthritis. RHB-104 is a combination of clarithromycin, clofazimine and rifabutin, three generic antibiotic ingredients, in a single capsule.
RHB-105
RHB-105, an antibiotics and proton pump inhibitor drug targeting Helico! bacter Pylori infection. RHB-105 is a combination of three approved drug products omeprazole, which is a proton pump inhibitor (the natural body pump that produces the gastric acids used for digesting the food in the stomach), and amoxicillin and rifabutin which are antibiotics. Chronic infection with Helicobacter pylori irritates the mucosal lining of the stomach and small intestine.
RHB-106
RHB-106, is a tablet for the preparation and cleansing of the gastrointestinal tract prior to the performance of abdominal procedures. Its abdominal procedures include diagnostic tests, such as colonoscopy, barium enema or virtual colonoscopy, as well as surgical interventions, such as laparotomy.
The company competes with GlaxoSmithKline, Sanofi-Aventis Groupe, Hoffman-La Roche Ltd, Merck and Co., Inc, Ferring Pharmaceuticals and Salix Pharmaceuticals Inc.
Advisors' Opinion:- [By Monica Gerson]
Breaking news
Vitran Corporation (NASDAQ: VTNC) announced today that it has entered into a definitive arrangement agreement with TransForce pursuant to which TransForce has agreed to acquire all of the outstanding common shares of Vitran not already owned by TransForce for US$6.50 in cash per share, in accordance with TransForce's prior proposal. To read the full news, click here. ReneSola (NYSE: SOL) today announced it signed a Memorandum of Intent (MOI) to sell three utility-scale projects in Western China, with a total capacity of 60MW, to Jiangsu Akcome Solar Science & Technology Co on December 30, 2013. To read the full news, click here. Cooper Tire & Rubber Company (NYSE: CTB) today announced it has terminated the merger agreement with Apollo Tyres (NSE:ApolloTYRE). To read the full news, click here. RedHill Biopharma (NASDAQ: RDHL) today announced that it has entered into a definitive agreement with leading healthcare investor OrbiMed Israel Partners Limited Partnership, an affiliate of OrbiMed Advisors LLC, for the sale of RedHill's American Depository Shares and warrants in a private placement transactionor a total sum of $6.0 million. To read the full news, click here.Posted-In: Guggenheim US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets
Top Trucking Stocks To Invest In Right Now: Spdr Dj Wilshire Small Cap Value Etf (SLYV)
SPDR DJ Wilshire Small Cap Value (ETF) seeks to replicate, as closely as possible, the performance of the Dow Jones Wilshire Small Cap Value Index (the Index). The Index represents the small-cap portion of the Dow Jones Wilshire 5000 Composite Index (the Composite Index). The Composite Index tracks all the United States common stocks regularly traded on the NYSE, the AMEX and the NASDAQ National Market.
The Index includes the components of the Composite Index ranked 751 to 2,500 by full market capitalization and that are classified as value based on analysis that accounts for six factors. The six factors are projected price-to-earnings ratio (P/E), projected earnings growth, price-to-book ratio, dividend yield, trailing revenue growth and trailing earnings growth. The Fund uses a passive management strategy designed to track the total return performance of the float-adjusted Index.
Advisors' Opinion:- [By Tom Lydon]
The following ETFs are some of the top-ranked small-cap ETFs by Zacks. SPDR S&P 600 Small Cap Value ETF (SLYV) is up 5.8% over the past three months, and up 20.6% in 2013. The financial and industrial sectors are top weightings. Vanguard S&P Small Cap 600 Value ETF (VIOV) is up 6.4% and has gathered 21.5% year-to-date. Similar to SLYV, VIOV is heavy on the financial and industrial sectors.
Top Trucking Stocks To Invest In Right Now: CONSOL Energy Inc (CNX)
CONSOL Energy Inc. (CONSOL Energy), incorporated in 1991, is a producer of coal and natural gas for global energy and raw material markets, which include the electric power generation industry and the steelmaking industry. During the year ended December 31, 2011, the Company produced 62.6 million tons of high-British thermal unit (Btu) bituminous coal from 12 mining complexes in the United States. In addition, it provides energy services, including river and dock services, terminal services, industrial supply services, coal waste disposal services and land resource management services. The Company operates in two segments: Coal and Gas. In July 2012, Cloud Peak Energy Inc. acquired Youngs Creek Mining Company, LLC (Youngs Creek) joint venture and other related coal and surface assets from Chevron U.S.A. Inc. (Chevron) and the Company.
Coal Operations
The principal activities of the Coal unit are mining, preparation and marketing of thermal coal, sold primarily to power generators, and metallurgical coal, sold to metal and coke producers. The Coal division consists of four reportable segments, which includes Thermal, Low Volatile Metallurgical, High Volatile Metallurgical and Other Coal. Each of these reportable segments includes a number of operating segments (mines or type of coal sold). During 2011, the Thermal aggregated segment included the Bailey, Blacksville #2, Enlow Fork, Fola Complex, Loveridge, McElroy, Miller Creek Complex, Robinson Run and Shoemaker mines. During 2011, the Low Volatile Metallurgical coal aggregated segment included the Buchanan mine. During 2011, the High Volatile Metallurgical coal aggregated segment included Bailey, Blacksville #2, Enlow Fork, Fola Complex, Loveridge, Miller Creek Complex and Robinson Run coal sales.
The Other Coal segment includes its purchased coal activities, idled mine activities, as well as various other activities assigned to the coal division but not allocated to each individual mine. During 2011, the Company! �� reserves were located in northern Appalachia (62%), the mid-western United States (17%), central Appalachia (15%), the western United States (4%), and in western Canada (2%). As of December 31, 2011, the Company had an estimated 4.5 billion tons of proven and probable reserves. During 2011, 94% of its production came from underground mines, 6% from surface mines, and 91% of its production came from mines equipped with longwall mining systems. As of December 31, 2011, CONSOL Energy operated 22 towboats, five harbor boats and a fleet of 625 barges that serve customers along the Ohio, Allegheny, Kanawha and Monongahela Rivers. During 2011, over 84% of all the coal it produced was sold under contracts with terms of one year or more.
Gas Operations
The principal activity of the Gas division is to produce pipeline methane gas for sale primarily to gas wholesalers. The Gas Division consists of four reportable segments, which include Coalbed Methane (CBM), Marcellus, Shallow Oil and Gas and Other Gas. The Other Gas segment includes its purchased gas activities, as well as various other activities assigned to the gas division but not allocated to each individual well type. Its gas division focuses on developing the Marcellus acreage position in southwest Pennsylvania, central Pennsylvania and northwest West Virginia. CONSOL Energy�� all Other segment includes terminal services, river and dock services, industrial supply services and other business activities. Its gas operations primarily produce CBM, which is a gas that resides in coal seams. The Company�� Coalbed Methane operations are located in central Appalachia in Southwest Virginia. Its CBM production also comes from northern Appalachia in northwestern West Virginia and southwestern Pennsylvania where it drills vertical-to-horizontal CBM wells.
As of December 31, 2011, the Company had rights to extract CBM in Virginia from approximately 359,000 net CBM acres, which cover a portion of its coal reserves in Cen! tral Appa! lachia. CONSOL Energy produces gas primarily from the Pocahontas #3 seam, which is the coal seam mined by its Buchanan Mine. The Company also has right to extract CBM in northwestern West Virginia and southwestern Pennsylvania from approximately 859,000 net CBM acres, which contains its recoverable coal reserves in Northern Appalachia. CONSOL Energy produces gas primarily from the Pittsburgh #8 coal seam.
In central Pennsylvania, the Company has the right to extract CBM from approximately 263,000 net CBM acres, which contains its recoverable coal reserves, as well as leases from other coal owners. In addition, CONSOL Energy controls 810,000 net CBM acres in Illinois, Kentucky, Indiana and Tennessee. It also has the right to extract CBM on 139,000 net acres in the San Juan Basin, 20,000 net acres in the Powder River Basin and 92,000 net acres in eastern Ohio and central West Virginia. Its Marcellus wells are primarily horizontal wells with 2,500 to 5,000 feet of lateral length. As of December 31, 2011, the Company had the right to extract natural gas in Pennsylvania, West Virginia and New York from approximately 361,000 net acres.
CONSOL Energy controls approximately 346,000 net acres of rights to gas in the New Albany shale in Kentucky, Illinois and Indiana. The New Albany shale is a formation containing gaseous hydrocarbons, and its acreage position has thickness of 50-300 feet at an average depth of 2,500-4,000 feet. CONSOL Energy has 249,000 net acres of Chattanooga Shale. It has 457,000 net acres of Huron shale in Kentucky and Virginia. During 2011, the Company drilled 254.9 net development wells and 47 net developmental wells.
Other Operations
CONSOL Energy provides other services to its own operations and others. These include land services, industrial supply services, terminal services, including break bulk, general cargo and warehouse services, and river and dock services water services. Fairmont Supply Company, which is CONSOL Energy�� subs! idiary, i! s a general-line distributor of mining, drilling, and industrial supplies in the United States. During 2011, approximately 12.6 million tons of coal was shipped through CNX Marine Terminal Inc.�� exporting terminal in the Port of Baltimore. CONSOL Energy�� river operations, located in Monessen, Pennsylvania, transport coal from its mines, coal from other mines and non-coal commodities from river loadout facilities located primarily along the Monongahela and Ohio Rivers in northern West Virginia and southwestern Pennsylvania.
As of December 31, 2011, it operated 22 towboats, five harbor boats and 625 barges. In 2011, its river vessels transported a total of 19.1 million tons of coal and other commodities, including 6.2 million tons of coal produced by CONSOL Energy mines. CONSOL Energy provides dock services for its mines, as well as for third parties at its Alicia Dock, located on the Monongahela River in Fayette County, Pennsylvania. Its subsidiary CNX Water Assets LLC acquires and develops existing sources of water used to support its coal and gas operations.
Advisors' Opinion:- [By Ben Levisohn]
Among S&P-500 mining stocks, Freeport McMoran Copper & Gold (FCX) has gained 2.6% to $31.00, Consol Energy (CNX) has jumped 2.5% to $32.00 and Newmont Mining (NEM) has fallen 0.3% to $31.44.
No comments:
Post a Comment